PMS-IC is delivering the analytical workspace for balancing recruitment/cohort effectiveness together with co-developing the EPAD engine for new adaptive clinical trials.
This major Initiative is aimed at creating a novel environment for testing interventions targeted at the prevention of Alzheimer’s dementia.
EPAD is a €64m project involving 36 EU partners awarded through the Medicines Initiative.
For more information, see: www.ep-ad.org
BACK TO PROJECTS